Hyperphagia: Clinical Trials

45 trials for Hyperphagia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

28 completed, 7 terminated, 6 unknown, 1 active not recruiting. 45 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 445Completed 28, Terminated 7, Unknown 6, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1

Follow Hyperphagia: new trials by email Literature Review of Hyperphagia trials Research Report on Hyperphagia

Trials (filtered) newest first · largest first

All 45 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Preoperative Parenteral Nutrition With Omega-3 Fish Oil Lipid Emulsion on Postoperative Outcomes in Patients Undergoing Major Abdominal Surgery
ω-3 fish oil lipid emulsion, Conventional lipid without ω-3 fish oil - Parenteral Nutrition, Nutritional Status
Phase 4Not yet recruitingSecond Affiliated Hospital of Nanchang University1582026-10-012026-10-16
Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity
Setmelanotide - Bardet Biedl Syndrome (BBS), Bardet Biedl Syndrome
Phase 4RecruitingTom Hühne2002023-01-012026-06-29
Personalized vs Standardized PN for Preterm Infants >1250g
Standardized-parenteral nutrition (S-PN), Personalized-parenteral nutrition (P-PN) - Infant,Premature, Parenteral Nutrition
Phase 4UnknownOspedali Riuniti Ancona1502021-07-042023-03-23
Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)
Clinolipid, Intralipid - Essential Fatty Acid Deficiency (EFAD)
Phase 4CompletedBaxter Healthcare Corporation1012021-01-222023-12-27
Supplemental Parenteral Nutrition During Postgastrectomy in Nutritionally at Risk Patient
Parenteral Nutrition Solutions - Gastric Cancer, Gastrectomy
Phase 4UnknownSeoul National University Hospital2242020-12-222021-09-24
Safety of Manganese Restriction in Neonatal Parenteral Nutrition
Manganese omission, 5 mCg/kg/day manganese from "Multitrace-4 Neonatal." - Infant, Newborn, Disease
Phase 4CompletedSharp HealthCare262020-06-112021-08-25
Effects of Fat Emulsions on PNALD and Oxidative Stress in Premature Infants
SMOFlipid, Lipofundin - Preterm Infant
Phase 4UnknownShanghai Jiao Tong University School of Medicine662020-02-012020-02-20
Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age
Smoflipid, Intralipid, 20% - Malnutrition, Child
Phase 4TerminatedFresenius Kabi12019-12-182022-12-12
The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns
Intralipid, 20% Intravenous Emulsion, Soybean oil Medium-chain triglycerides Olive oil Fish Oil (SMOF) lipid - Prematurity
Phase 4CompletedThe University of Texas Health Science Center, Houston662019-03-022025-03-03
Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients
Teduglutide - Short Bowel Syndrome
Phase 4CompletedAssistance Publique - Hôpitaux de Paris252018-07-022025-09-11
Study to Assess Safety and Efficacy of Kabiven® in Pediatric Patients 2 to 16 Years of Age
Kabiven®, Compounded standard parenteral nutrition - Malnutrition
Phase 4WithdrawnFresenius Kabi2018-03-012019-09-04
Insulin in Total Parenteral Nutrition
Subcutaneous glargine insulin, Regular insulin added to TPN bag - Diabetes Mellitus
Phase 4CompletedFundación Pública Andaluza Progreso y Salud1632016-07-012018-05-24
Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF.
Antidepressants, Positron Emission Tomography (PET) - Bulimia Nervosa
Phase 4CompletedCentre Hospitalier Universitaire de Saint Etienne512015-11-092022-11-30
Pilot Study: Hepatoprotective Role of SMOFlipid® Used in Short-term Parenteral Nutrition in an Onco-Hematology Pediatric Population
Smoflipid, Médialipides - Dietary and Nutritional Therapies
Phase 4CompletedCentre Hospitalier Universitaire de Nice92015-06-012017-04-13
Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion
Clinolipid, Intralipid - Essential Fatty Acid Deficiency (EFAD)
Phase 4TerminatedBaxter Healthcare Corporation12015-05-012021-07-21
Dosing Study of Amino Acids in Seriously Ill Patients
15% CLINISOL - Sulfite-free (Amino Acid) Injection - Parenteral Nutrition (No Primary Condition Studied)
Phase 4TerminatedBaxter Healthcare Corporation162013-07-012017-03-27
Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils
Intralipid, ClinOleic - Obstruction, Cancer
Phase 4CompletedJohane Allard3032013-07-012025-02-03
Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)
Glargine Insulin, Regular insulin - Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition
Phase 4CompletedKing Faisal Specialist Hospital & Research Center612013-03-012016-02-25
Different Lipid Emulsions in Acute Lung Injury Patients
Lipoplus 20%, Lipofundin N 20% - Parenteral Nutrition
Phase 4TerminatedB. Braun Melsungen AG12013-03-012016-07-20
Hepatic Function and Bile Acid in Preterm Infants Receiving Parenteral Lipids Emulsion
ClinOleic, Intralipid - Preterm Infants
Phase 4UnknownShanghai Jiao Tong University School of Medicine1002012-10-012013-02-08

Showing 20 of 45. Sign in to see all of them.

Narrower conditions

Bulimia (5)  ·  Malnutrition (5)  ·  Premature Birth (5)  ·  Short Bowel Syndrome (4)  ·  Critical Illness (3)  ·  Obesity (3)  ·  Cholestasis (2)  ·  Gastrointestinal Diseases (2)  ·  Infections (2)  ·  Insulin Resistance (2)  ·  Intestinal Failure (2)  ·  Liver Failure (2)  ·  Pena Shokeir syndrome, type 1 (2)  ·  Stomach Neoplasms (2)

Broader conditions

Pathological Conditions, Signs and Symptoms (45)  ·  Signs and Symptoms (45)  ·  Signs and Symptoms, Digestive (45)  ·  Digestive System Diseases (17)  ·  Pathologic Processes (12)  ·  Nutritional and Metabolic Diseases (11)  ·  Gastrointestinal Diseases (9)  ·  Nutrition Disorders (9)  ·  Intestinal Diseases (7)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Urogenital Diseases (6)  ·  Digestive System Neoplasms (5)  ·  Neoplasms (5)  ·  Neoplasms by Site (5)

Interventions

soybean oil, phospholipid emulsion (10)  ·  SMOFlipid (6)  ·  ClinOleic (5)  ·  Olive Oil (3)  ·  Parenteral Nutrition (3)  ·  alanylglutamine (3)  ·  Injections (2)  ·  Insulin (2)  ·  Insulin Glargine (2)  ·  Lipofundin (2)  ·  Soybean Oil (2)  ·  fish oil triglycerides (2)  ·  Amino Acids (1)  ·  Antidepressive Agents (1)  ·  BaseLine dental cement (1)

Sponsors

Baxter Healthcare Corporation (3)  ·  Fresenius Kabi (3)  ·  Shanghai Jiao Tong University School of Medicine (2)  ·  Yale University (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  B. Braun Medical SA (1)  ·  B. Braun Melsungen AG (1)  ·  Centre Hospitalier Universitaire de Nice (1)  ·  Centre Hospitalier Universitaire de Saint Etienne (1)  ·  Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)  ·  Fernandes Tavora Hospital (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Fundación Pública Andaluza Progreso y Salud (1)  ·  General University Hospital, Prague (1)  ·  Hospital Sant Joan de Deu (1)

Countries

United States (13)  ·  China (6)  ·  Spain (5)  ·  Germany (4)  ·  Belgium (3)  ·  France (3)  ·  Argentina (1)  ·  Austria (1)  ·  Brazil (1)  ·  Canada (1)  ·  Czechia (1)  ·  Guatemala (1)  ·  Italy (1)  ·  Poland (1)  ·  Saudi Arabia (1)

Top investigators

Alessandro Pontes-Arruda, MD, MSc, PhD, FCCM (1)  ·  Alexander P Wilmer, MD Ph D (1)  ·  Alfonso Bonet Saris, MD_Study Coordinator (1)  ·  Andreas Repa, MD (1)  ·  Bin Cai, M.D (1)  ·  Carlos M Grilo, PhD (1)  ·  Carlos M. Grilo, PhD (1)  ·  Cody Arnold, MD (1)  ·  Daniel Cardona Pera, Doctor (1)  ·  Erik B Nelson, MD (1)  ·  Fedja Rochling, MB, ChB (1)  ·  Frantisek Novak, MD, PhD (1)

Results publications

PMID 10022643, PMID 17919374, PMID 18650630, PMID 21261975, PMID 21714640, PMID 21820770, PMID 22269899, PMID 22632574, PMID 23204255, PMID 23348400, PMID 23376451, PMID 23506003, PMID 24461665, PMID 24825371, PMID 24857821, PMID 25622201, PMID 26214545, PMID 26266842, PMID 26561301, PMID 26708726, PMID 27614675, PMID 28130688, PMID 28475354, PMID 29269199, PMID 30930133, PMID 31030946, PMID 31361307, PMID 31481633, PMID 31502272, PMID 31970446, PMID 32590001, PMID 32928255, PMID 33712505, PMID 34582624, PMID 34816288, PMID 34915907, PMID 35274472, PMID 36257349, PMID 37270289, PMID 39017697, PMID 39672082, PMID 40415417, PMID 40493222, PMID 40903014, PMID 42437371

NIH funding

2005 (1), 2015 (1), 2017 (1), 2018 (1), R01DK073542 (1)